2.40
price down icon7.01%   -0.1808
after-market Dopo l'orario di chiusura: 2.40
loading
Precedente Chiudi:
$2.5808
Aprire:
$2.5
Volume 24 ore:
9,741
Relative Volume:
0.31
Capitalizzazione di mercato:
$42.70M
Reddito:
-
Utile/perdita netta:
$-21.91M
Rapporto P/E:
-13.06
EPS:
-0.1837
Flusso di cassa netto:
-
1 W Prestazione:
+8.11%
1M Prestazione:
+46.34%
6M Prestazione:
+0.42%
1 anno Prestazione:
+118.10%
Intervallo 1D:
Value
$2.40
$2.50
Intervallo di 1 settimana:
Value
$2.20
$2.73
Portata 52W:
Value
$0.80
$12.68

Incannex Healthcare Inc Stock (IXHL) Company Profile

Name
Nome
Incannex Healthcare Inc
Name
Telefono
61 409 840 786
Name
Indirizzo
401 DOCKLANDS DRIVE, DOCKLANDS, VICTORIA
Name
Dipendente
9
Name
Cinguettio
Name
Prossima data di guadagno
Name
Ultimi documenti SEC
Name
IXHL's Discussions on Twitter

Incannex Healthcare Inc Borsa (IXHL) Ultime notizie

pulisher
Oct 25, 2024

Incannex Healthcare names Lou Barbato as chief medical officer - MSN

Oct 25, 2024
pulisher
Oct 24, 2024

Incannex appoints new chief medical officer - Investing.com India

Oct 24, 2024
pulisher
Oct 24, 2024

Incannex appoints new chief medical officer By Investing.com - Investing.com South Africa

Oct 24, 2024
pulisher
Oct 24, 2024

Incannex Announces Appointment of Dr. Lou Barbato as Chief Medical Officer - GlobeNewswire

Oct 24, 2024
pulisher
Oct 24, 2024

Incannex Healthcare Appoints Dr. Barbato as CMO - TipRanks

Oct 24, 2024
pulisher
Oct 22, 2024

Incannex Healthcare Leads The Charge On US Penny Stocks With 2 Other Notable Picks - Simply Wall St

Oct 22, 2024
pulisher
Oct 22, 2024

Incannex Healthcare secures $3.3 million through debt financing By Investing.com - Investing.com Australia

Oct 22, 2024
pulisher
Oct 21, 2024

Incannex Healthcare secures $3.3 million through debt financing - Investing.com

Oct 21, 2024
pulisher
Oct 17, 2024

Incannex Healthcare secures A$6.9 million funding By Investing.com - Investing.com Australia

Oct 17, 2024
pulisher
Oct 15, 2024

Incannex Healthcare secures A$6.9 million funding - Investing.com

Oct 15, 2024
pulisher
Oct 03, 2024

Incannex Provides Business Updates and Progress on OSA Drug Candidate in Phase 2/3 Trials - Sleep Review

Oct 03, 2024
pulisher
Oct 02, 2024

Stonegate Initiates Coverage on Incannex Healthcare Inc. (IXHL) - Invezz

Oct 02, 2024
pulisher
Oct 01, 2024

R&D tax breaks buoy Incannex as losses narrow - Green Market Report

Oct 01, 2024
pulisher
Sep 30, 2024

Incannex Healthcare Inc. (NASDAQ:IXHL) Sees Significant Growth in Short Interest - Defense World

Sep 30, 2024
pulisher
Sep 30, 2024

Incannex Healthcare Inc. Reports Fiscal Full Year 2024 Financial Results and Business Updates - The Manila Times

Sep 30, 2024
pulisher
Sep 13, 2024

Incannex Healthcare Inc. (NASDAQ:IXHL) Short Interest Update - MarketBeat

Sep 13, 2024
pulisher
Sep 11, 2024

Incannex Secures Up to $60M in Financing to Support Clinical Trials - Sleep Review

Sep 11, 2024
pulisher
Sep 10, 2024

Incannex secures financing deal valued at US$60 million - Mugglehead

Sep 10, 2024
pulisher
Sep 10, 2024

Incannex $60 Million Deal With Arena For Late-Stage Drug TrialsIncannex Healthcare (NASDAQ:IXHL) - Benzinga

Sep 10, 2024
pulisher
Sep 10, 2024

Incannex Healthcare secures $60 million funding via equity and debt - Investing.com

Sep 10, 2024
pulisher
Sep 10, 2024

Incannex Healthcare secures $60 million funding via equity and debt By Investing.com - Investing.com UK

Sep 10, 2024
pulisher
Sep 10, 2024

Incannex Healthcare lands $60 million financing deal - Green Market Report

Sep 10, 2024
pulisher
Sep 10, 2024

Incannex Healthcare Announces Strategic Financing for up to $60 Million with Arena Investors - GlobeNewswire

Sep 10, 2024
pulisher
Sep 10, 2024

Incannex secures $60 million in funding for clinical trials - Investing.com

Sep 10, 2024
pulisher
Aug 29, 2024

Incannex Healthcare Inc. (NASDAQ:IXHL) Sees Large Growth in Short Interest - MarketBeat

Aug 29, 2024
pulisher
Aug 15, 2024

Thinking about buying stock in Altimmune, UiPath, Incannex Healt - GuruFocus.com

Aug 15, 2024
pulisher
Aug 09, 2024

Virtu Financial LLC Buys New Shares in Incannex Healthcare Inc. (NASDAQ:IXHL) - Defense World

Aug 09, 2024
pulisher
Aug 06, 2024

4 Psychedelic Stocks to Consider as Clinical Trials Heat up - Investing.com

Aug 06, 2024
pulisher
Aug 05, 2024

FDA Review of PsiGAD2 IND complete; clinical trial for - GlobeNewswire

Aug 05, 2024
pulisher
Aug 05, 2024

FDA Clears Incannex To Proceed With Phase 2 Psilocybin-Assisted Therapy Trial For Anxiety - Benzinga

Aug 05, 2024
pulisher
Aug 05, 2024

Incannex Healthcare gets FDA nod for Phase 2 trial - Green Market Report

Aug 05, 2024
pulisher
Aug 05, 2024

FDA Review of PsiGAD2 IND complete; clinical trial for Psilocybin Assisted Psychotherapy in Patients with Generalised Anxiety Disorder to Proceed - StockTitan

Aug 05, 2024
pulisher
Aug 04, 2024

Tidal Investments LLC Buys New Stake in Incannex Healthcare Inc. (NASDAQ:IXHL) - MarketBeat

Aug 04, 2024
pulisher
Aug 04, 2024

Tidal Investments LLC Acquires Shares of 423,410 Incannex Healthcare Inc. (NASDAQ:IXHL) - Defense World

Aug 04, 2024
pulisher
Jul 30, 2024

Dosing completed in 115 participant bioavailability/bioequivalence clinical trial for proprietary sleep apnea drug candidate IHL-42X - GlobeNewswire

Jul 30, 2024
pulisher
Jul 19, 2024

Head to Head Review: Zai Lab (NASDAQ:ZLAB) vs. Incannex Healthcare (NASDAQ:IXHL) - Defense World

Jul 19, 2024
pulisher
Jul 11, 2024

Incannex Healthcare Inc. (NASDAQ:IXHL) Short Interest Down 69.0% in June - MarketBeat

Jul 11, 2024
pulisher
Jun 12, 2024

7 Best Psychedelic Stocks in 2024 | Investing - U.S News & World Report Money

Jun 12, 2024
pulisher
May 31, 2024

Patient Dosing Begins in Phase 2/3 Trial for OSA Drug Candidate IHL-42X - Sleep Review

May 31, 2024
pulisher
May 30, 2024

Patient dosing commenced in RePOSA Phase 2/3 Clinical Trial Protocol to Assess IHL-42X Drug in Patients with Obstructive Sleep Apnea - Yahoo Finance

May 30, 2024
pulisher
May 07, 2024

Incannex Complete Successful Pre-IND Meeting with the FDA for CannQuit-O for treatment of opioid use disorder - Yahoo Finance

May 07, 2024
pulisher
Apr 16, 2024

'Truly Remarkable’ Results Spur Incannex's Phase 2/3 Trials for Sleep Apnea Drug Candidate, Says CEO - Sleep Review

Apr 16, 2024

Incannex Healthcare Inc Azioni (IXHL) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$12.67
price up icon 0.88%
$114.96
price down icon 0.42%
$89.24
price up icon 3.56%
$58.48
price down icon 0.36%
$121.53
price up icon 0.83%
$11.61
price up icon 1.40%
Capitalizzazione:     |  Volume (24 ore):